Healthcare Industry News: abdominal aortic aneurysm
News Release - January 23, 2013
Improved GORE(R) DrySeal Sheath with Hydrophilic Coating Launches in EuropeNew Product Engineered to Increase Sheath Lubricity, Minimize Coating Particulation for Easier Insertion and Removal in Treating Patients with AAA and TAA
FLAGSTAFF, Ariz.--(Healthcare Sales & Marketing Network)--W. L. Gore & Associates (Gore) today introduced GORE® DrySeal Sheath with hydrophilic coating in Europe. The new GORE DrySeal Sheath allows for easier insertion into and removal from blood vessels during endovascular repair procedures. The device is designed to increase sheath lubricity with an advantage of minimizing particulation of the hydrophilic coating.
“Adding hydrophilic coating to this Gore device provides physicians with more control when performing endovascular repair,” said Thomas Larzon, MD, Head of Vascular Surgery, Department of Cardiovascular and Thoracic Surgery, Örebro University Hospital, Örebro, Sweden. “This advantage greatly benefits patients as it helps minimize unnecessary blood loss when inserting endovascular devices.”
The GORE DrySeal Sheath is comprised of the innovative hemostatic GORE DrySeal Sheath valve attached to the introducer sheath. The GORE DrySeal Sheath valve is truly unique in that it is pressurized to create a seal, thereby minimizing blood loss and accommodating multiple wires and catheters simultaneously. The valve consists of a silicone outer tube and an inner film tube that create an effective hemostatic seal that easily adapts to the profiles of the inserted devices.
Gore Aortic Business Leader Ryan Takeuchi added, “Gore strives to deliver physicians with superior performance through quality of design, which is evident in the product enhancement introduced today.”
Gore received CE Mark approval for the GORE DrySeal Sheath in April 2010. The device is used in conjunction with the GORE® EXCLUDER® AAA Endoprosthesis to aid in the minimally invasive treatment of patients with abdominal aortic aneurysms (AAA). It is also used with the Conformable GORE® TAG® Thoracic Endoprosthesis in patients with isolated lesions of the Descending Thoracic Aorta (DTA).
ABOUT W. L. GORE & ASSOCIATES
The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 35 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac, and general surgery. Gore was recently named one of the best companies to work for by Fortune magazine for the 15th consecutive year. For more information, visit www.goremedical.com.
Products listed may not be available in all markets. GORE®, EXCLUDER®, TAG®, and designs are trademarks of W. L. Gore & Associates.
Source: W. L. Gore
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.